Sun Pharmaceutical Industries: Strong Q1 Beat on All Fronts but Upside Capped
In the US, Sun diversifying into specialty products like Ilumya, Levulan, BromSite, Cequa, Xelpros, Odomzo, Yonsa, winlwvi etc. Key Risk: (i) Price...
132 Views
HSIE Results Daily: Sun Pharma, Bharat Petroleum Corporation, Eicher Motors, Cadila Healthcare, V...
V-Guard Industries: V-Guard posted in-line but strong revenue growth of 58% YoY (HSIE 59%), clocking 2-year revenue CAGR of 7%. South region posted...
160 Views
Domestic Formulation on steady footing
Sun Pharma (SUNP) delivered a 4QFY21 performance marginally below our expectations, weighed by moderation in US and API sales. Domestic Formulation...
257 Views